Home / Fact sheets / Mozambique / Breast qualitative data

Country fact sheet: Mozambique

BREAST CANCER SCREENING PROGRAMME

Reporting year for qualitative data: 2020
Source of qualitative data: Directly from Programme

Organization of screening

An individual/team/institution responsible to coordinate the programme: Yes
Dedicated budget for screening programme: Yes
Documented cancer screening policy: Yes
Nature of documentation of the policy: Notification
Year programme was initiated: 2009
Programme introduction was preceded by a pilot: No
Screening tests provided free of charge: Yes
Diagnostic tests provided free of charge: Yes
Treatment services provided free of charge: Yes

Information system and data collection

System that collects data: Aggregated
   • Identification of eligible population: -
   • Screening participation: Aggregated
   • Screening test results: Aggregated
   • Further assessment: No
   • Final pathology diagnosis: No
   • Cancer staging: No
   • Treatment: No
The information system exists at national or sub-national level: Individual: Unknown
Aggregated: National
The information system collects data outside the programme (opportunistic screening/private sector): Yes
Cancer screening data is linked with population-based cancer registry (PBCR): PBCR exists but not linked

Screening protocol

A screening protocol or guideline: Yes
Year of published/updated protocol: 2020
Target age (min-max) and screening interval [months] for each test: CBE (25-45 years / [12 months])
All mammograms read by two radiologists independently: -

Invitations for screening and further assessment

Initiatives to create population awareness by the Health Ministry/Health Authority: Mass media campaign
Small media campaign
Group education
One-on-one education
Social media platform
Invitations to eligible population: No
Source of the eligible individuals identified: -
Method of invitation: -
Screen positive individuals actively contacted for further assessment: Yes
Individuals with a precancer or cancer diagnosis actively contacted: Yes

Quality Assurance (QA) of screening activities

Documented standard operating procedure/policy for QA: No
An individual/team/institution responsible for QA: Yes
Accreditation of mammography units: No
Accreditation of pathology services: No
Documented performance indicators: Yes
Reference standards for performance indicators: No
Evaluation reports published in the last five years: Yes

Performance indicators

Reporting year for quantitative data: 2020
Source of quantitative data: Directly from programme
Age range and regional limitation if applicable: 25-45 years
Invitation coverage (%):
Participation rate (%):
Examination coverage (%): 54.9
Completeness of data related to screening test results (%): 100.0
Completeness of data related to further assessment results (%):
Further assessment rate (%): 1.0
Further assessment participation rate (%):
Detection rate of CIS (x 1000):
Detection rate of invasive cancer (x 1000):
Detection rate of CIS and invasive cancer (x 1000):
Positive Predictive Value of abnormal screening test to detect CIS (x 1000):
Positive Predictive Value of invasive cancer (x 1000):
Positive Predictive Value of CIS and invasive cancer (x 1000):
More quantitative data (2020)


Check also the following factsheets: Mozambique, Cervical, Colorectal